
Aiwei Pharma
艾威药业
Aiwei Pharma
Biotech/Healthcare
Aiwei Pharmaceuticals is an ophthalmic innovative drug developer conducting R&D and drug registration filings in both China and the United States. Its core team consists of scientists and clinicians from China and the U.S.
Latest round: Series A Extension (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.